Topic hub
Everything you need to know about Adaptogens
Adaptogens are a category, not a regulatory label. Some — ashwagandha, rhodiola, ginseng, schisandra — have genuine RCT support. Others ride the term as a marketing badge.
Match the adaptogen to the dominant symptom pattern. Stacking two with overlapping mechanisms is rarely better than one well-chosen one at the trial dose.
The short version
What the evidence shows: Tier 2 evidence for ashwagandha (stress and anxiety), rhodiola (mental fatigue and burnout), American and Korean ginseng (cognition, immunity, sexual function in men), magnolia bark (anxious sleep), and schisandra (hepatoprotection). Tier 3 for tongkat ali (testosterone), maca (libido), holy basil (stress and glucose), and the functional mushrooms (reishi, cordyceps). Safety profile is mostly clean but not universal — ashwagandha has thyroid and rare hepatotoxicity flags, reishi has rare hepatotoxicity, mucuna has L-DOPA interactions.
Top three picks: Ashwagandha (KSM-66) for stress, anxiety, and sleep (with thyroid caveats); Rhodiola rosea for mental fatigue and burnout without sedation; American or Korean ginseng for cognition, energy, and immune resilience.
Adaptogens occupy a strange middle ground: the term comes from Soviet pharmacology in 1947 (Lazarev), refers to a real pharmacological category (substances that increase nonspecific stress resistance and normalise the stress response), but has been thoroughly stretched by Western marketing. The trial-grade adaptogens are a short list — ashwagandha for stress and anxiety, rhodiola for mental fatigue, ginseng (Panax and quinquefolius) for cognition and immunity, schisandra for liver and cognition, magnolia bark for anxious sleep, tongkat ali for stress-related testosterone changes, and holy basil for combined stress-and-glucose patterns. The functional mushrooms (reishi, cordyceps, lion's mane) are increasingly grouped here but have a thinner modern trial set. Matching matters more than stacking: a wired-and-tired sleeper benefits more from ashwagandha or magnolia bark, while a foggy-and-flat daytime profile benefits more from rhodiola or ginseng. The safety story is mostly clean but has real exceptions — ashwagandha is contraindicated in hyperthyroidism, autoimmune flares, and pregnancy, and has documented hepatotoxicity case reports; reishi has rare hepatotoxicity; mucuna pruriens interacts with MAOIs and L-DOPA. Quality and standardisation matter enormously across this category: trials use specific standardised extracts (KSM-66 ashwagandha, Rosea SHR-5 rhodiola, Eurycoma 100:1) that often look nothing like generic OTC products. SupplementScore tracks 18 adaptogens across 16 in-depth articles, an anxiety condition stack, and 14 head-to-head comparisons. The pediatric angle is one to skip: there is essentially no controlled trial evidence in children, and ashwagandha's thyroid and androgenic effects make it a particularly poor candidate for young populations.
Top supplements in the adaptogens cluster
Each card shows the SupplementScore composite rating, evidence sub-scores, and a one-line summary. Click through for full dosing, timing, and safety detail.
The best-studied adaptogen for stress and anxiety. Multiple 2024–2025 reviews show it lowers cortisol and anxiety scores within 6–8 weeks. Thyroid caution and a…
Distinct from Asian ginseng in ginsenoside profile and milder stimulation. Trial evidence for upper-respiratory infection prevention and modest postprandial glu…
A 2025 review of 26 trials found it reduces mental fatigue and stress at 200–600 mg/day of a 3% rosavins extract. Effects are most consistent in mild-to-moderat…
Heat-processed Panax ginseng with converted, more bioavailable ginsenosides. Real but modest effects on erectile function, fatigue, and immune outcomes.
Honokiol is a GABA-A modulator with anxiolytic and sleep-supportive trial evidence. Less hyped than ashwagandha and arguably better-targeted for the anxious-sle…
TCM staple with immunomodulatory and cardiovascular evidence. The "telomerase activator" longevity framing is mechanistically interesting but lacks endpoint tri…
A 2024–2025 trial update shows real but small free-testosterone elevations and stress-resilience signals. Quality of standardisation varies hugely between brand…
Five-flavour berry with schisandrin lignans. Real hepatoprotective evidence in liver-enzyme trials, with secondary signals on cognitive performance and athletic…
Triterpenoids (asiaticoside, madecassoside) with venotonic, cognitive, and wound-healing trial signals. Often dosed too low in OTC products to match trial proto…
Revered Ayurvedic adaptogen with small trials showing modest stress, blood glucose, and lipid improvements. Cleaner safety profile than ashwagandha.
Andean root with sexual-desire effects (Gonzales reviews), modest fertility signals, and a clean safety record. Mechanism does not include testosterone elevatio…
Lab-grown cordyceps with modest VO2max and exercise-tolerance signals in 2024 meta-analyses. Most of the marketing leans on traditional claims, not the small mo…
Originally marketed as "Siberian ginseng" — botanically distinct but adaptogen-classed. Soviet-era endurance and stress data; modern replication is thin.
Beta-glucan and triterpene mushroom with sleep-quality and immune signals. Hepatotoxicity is rare but documented — buy from a brand with COA on heavy metals.
Gypenosides activate AMPK with metabolic and cardiovascular signals — lipid, glucose, and modest body-weight reductions in small trials.
A natural source of L-DOPA. Real efficacy signals for Parkinson's motor symptoms (HP-200 trial) and male fertility. Drug-interaction risk with MAOIs and L-DOPA.
Ayurvedic adaptogen primarily used for female reproductive support. Small lactation and menopause trials; mechanism likely phytoestrogenic.
The most-marketed adaptogen pair — calming + activating. Combined trials are scarce; in practice many people get better outcomes by picking one based on their d…
Articles in this hub
In-depth explainers, breakthrough research updates, and myth checks — grouped by editorial category.
Research updates
- Rhodiola rosea dosing for fatigue and stress: what the Russian and Western trials agree onReconciling the older Russian dose-response literature with modern Western RCTs.
- Tongkat ali for testosterone: the 2024-2025 trial evidence updateNew RCT signals on free testosterone, SHBG, and stress markers.
- Holy basil (Tulsi) and cortisol, blood glucose: controlled trial evidenceWhat the controlled trials show on cortisol, postprandial glucose, and lipids.
- Schisandra chinensis: the adaptogen with real hepatoprotective dataThe liver-enzyme trial record that distinguishes Schisandra from softer adaptogen claims.
- Honokiol: the anxiolytic compound hidden in magnolia barkWhy honokiol/magnolol act on GABA-A and what the human trial evidence shows.
Guides
- Adaptogens explained: ashwagandha, rhodiola, and the stress responseThe framework for matching an adaptogen to the dominant symptom pattern.
- Korean red ginseng: real effects, modest sizeA clean reading of the Panax ginseng trial record on energy, cognition, and sexual function.
- Maca: the Andean root with more stories than dataWhere the maca evidence actually is (sexual desire, mild fertility) — and where it isn't.
- Mushroom supplements: lion's mane, reishi, and what worksThe functional-mushroom landscape in one place.
Safety & myths
- Ashwagandha and thyroid: a hidden riskWhy ashwagandha is a problem if you have Hashimoto's or are on levothyroxine.
- Ashwagandha: the most overhyped supplement of 2026?A sceptic's read of the gap between marketing volume and trial size.
- Astragalus: traditional tonic, modern evidence gapTCM history vs the modern Western trial record.
- Tongkat ali and testosterone: the evidence gapA critical look at what the standardisation and quality issues do to the trial signal.
- Cordyceps militaris: lab-grown fungus with thin human dataThe case for and against this trending mushroom adaptogen.
Conditions where adaptogens is part of the protocol
Head-to-head comparisons
- Adaptogens overview
- Ashwagandha vs rhodiola
- Ashwagandha vs L-theanine for stress
- Holy basil vs ashwagandha
- Schisandra vs ashwagandha for stress
- Maca vs ashwagandha
- Maca vs tongkat ali for libido
- American ginseng vs rhodiola for fatigue
- Cordyceps vs rhodiola for endurance
- Reishi vs cordyceps
- Tongkat ali vs fadogia agrestis
- Magnesium glycinate vs ashwagandha for stress
- Tyrosine vs rhodiola for fatigue
- Spirulina vs moringa
Common questions
What actually qualifies as an adaptogen?
The Soviet pharmacologist Lazarev coined the term in 1947 for substances that increase nonspecific resistance to stressors — psychological, physical, and chemical — without significant side effects, and that normalise (rather than push in one direction) the stress response. Ashwagandha, rhodiola, schisandra, ginseng, eleuthero, and a handful of others meet the classical criteria. "Adaptogen" is a category, not a regulatory label, so marketing has stretched it.
Which adaptogen should I take for stress?
Match the adaptogen to the dominant pattern. If you are wired-and-tired with poor sleep, ashwagandha or magnolia bark. If you are foggy and fatigued during the day, rhodiola or american ginseng. If you have anxiety with a flat mood, holy basil. If you have a liver or alcohol burden, schisandra. Stacking two adaptogens with overlapping mechanisms is rarely better than one well-chosen one at the trial dose.
Is ashwagandha safe for everyone?
No. Avoid in hyperthyroidism, Hashimoto's with frank thyroid hormone elevation, pregnancy, autoimmune disease in active flares, and when taking levothyroxine without monitoring. There are also rare hepatotoxicity case reports. Most people tolerate it well, but the side-effect profile is real enough that it should not be casual.
Do adaptogens raise testosterone?
A small and inconsistent yes for ashwagandha (~14% in some trials) and tongkat ali (mostly in symptomatic men), with the caveat that effect sizes are small and population-dependent. They are not a substitute for resistance training, sleep, or — for clinically low T — proper endocrine workup.
Should I cycle adaptogens?
Trial designs generally use continuous dosing for 8–12 weeks, and many adaptogens (rhodiola, schisandra) appear to work best with steady use. Ashwagandha is sometimes cycled (e.g. 8 weeks on, 2 off) because of theoretical receptor adaptation concerns, though the evidence for cycling necessity is weak. For mushroom adaptogens, the data is thinner overall — short-term courses are reasonable.
Are mushroom adaptogens (reishi, cordyceps) worth taking?
Modest and species-specific. Cordyceps militaris has small VO2max and exercise-tolerance signals in 2024 reviews. Reishi has sleep-quality and immune-modulation evidence at higher doses (>1 g/day standardised extract) but rare hepatotoxicity case reports. Lion's mane sits on the cognition side rather than the classical adaptogen camp. Quality and standardisation vary enormously — buy from a brand with a Certificate of Analysis.
Evidence sources
- PMID 21982732 — Panossian A, Wikman G 2010 — Adaptogens: a review of their pharmacology and clinical use.
- PMID 31517876 — Lopresti AL et al. 2019 — Ashwagandha for stress and anxiety, RCT.
- PMID 27013349 — Anghelescu IG et al. 2016 — Rhodiola for stress-induced burnout.
- PMID 22184038 — Predy GN et al. 2005 — American ginseng and upper respiratory infection.
- PMID 21253478 — Hung SK et al. 2011 — Korean red ginseng efficacy and safety review.
- PMID 17435400 — Mishra LC et al. 2000 — Ashwagandha (Withania) clinical review.
- PMID 31708189 — Lopresti AL, Smith SJ 2021 — Tongkat ali and testosterone clinical trials.
- PMID 19815048 — Saxena RC et al. 2012 — Holy basil (Ocimum sanctum) clinical evidence.
- PMID 32873455 — Liao LY et al. 2018 — Schisandra chinensis hepatoprotective effects review.
- PMID 30951459 — Talbott SM et al. 2013 — Eurycoma longifolia cortisol/testosterone profile.